SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-22-005658
Filing Date
2022-08-15
Accepted
2022-08-15 08:00:35
Documents
17
Period of Report
2022-08-15

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_081522.htm 6-K 10807
2 EXHIBIT 99.1 exh_991.htm EX-99.1 235396
3 EXHIBIT 99.2 exh_992.htm EX-99.2 184227
4 EXHIBIT 99.3 exh_993.htm EX-99.3 5521
5 EXHIBIT 99.4 exh_994.htm EX-99.4 5486
6 EXHIBIT 99.5 exh_995.htm EX-99.5 14772
7 GRAPHIC logo.jpg GRAPHIC 8233
8 GRAPHIC exh992_7.jpg GRAPHIC 86753
9 GRAPHIC exh992_8.jpg GRAPHIC 60440
10 GRAPHIC exh992_9.jpg GRAPHIC 34958
11 GRAPHIC exh992_p9.jpg GRAPHIC 39000
12 GRAPHIC exh992_10.jpg GRAPHIC 23686
13 GRAPHIC exh992_p10.jpg GRAPHIC 38752
14 GRAPHIC exh992_11.jpg GRAPHIC 42234
15 GRAPHIC exh992_12.jpg GRAPHIC 69826
16 GRAPHIC exh992_13.jpg GRAPHIC 38566
17 GRAPHIC exh992_p13.jpg GRAPHIC 48458
  Complete submission text file 0001171843-22-005658.txt   1134736
Mailing Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2
Business Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2 416 648-5555
Medicenna Therapeutics Corp. (Filer) CIK: 0001807983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-39458 | Film No.: 221162412
SIC: 2834 Pharmaceutical Preparations